1. Home
  2. Companies
  3. ENP
  4. Announcements

Entropy Neurodynamics (ASX:ENP)

ASX announcement history & article coverage

24
Total announcements
(in last 3 months)
5
With article
19
No article
Article coverage
21%
Transparent by design. Announcments by Entropy Neurodynamics (ASX:ENP) are listed here, whether we covered it or not. Where we've written an article, you'll see it linked directly. Where we haven't, the filing is still shown so nothing is hidden from view. If you think a particular announcement deserved editorial coverage and was overlooked, you can flag it for review and our team will take a look.

10 July 2026 · 09:07 am AEST ASX Filing
Additional Australian patent granted
Progress Report
9 July 2026 · 11:13 am AEST ASX Filing
Investor Presentation
Company Presentation
7 July 2026 · 09:37 am AEST ⚡ Price Sensitive ASX Filing
100% Clinical improvement, 50% Remission in BED study
Web CastTrading Halt Lifted
3 July 2026 · 09:09 am AEST ⚡ Price Sensitive ASX Filing
Trading Halt
Trading Halt

26 June 2026 · 12:29 pm AEST ASX Filing
Application for quotation of securities - ENP
Appendix 2A
26 June 2026 · 12:25 pm AEST ASX Filing
Top 20 Option Holders & Distribution Schedule
Top 20 shareholdersIssued Capital - Other
25 June 2026 · 05:27 pm AEST ASX Filing
Proposed issue of securities - ENP
Appendix 3B (Proposed issue of securities)
25 June 2026 · 05:12 pm AEST ASX Filing
Short Form Prospectus
Issued Capital - OtherDisclosure Document
15 June 2026 · 09:55 am AEST ⚡ Price SensitiveMaterial ASX Filing
DSMB Clears TRP 8803 to Advance to Cohort 2
Entropy Neurodynamics DSMB endorses safe progression of TRP-8803 Binge Eating Disorder trial to Cohort 2
Progress Report
75
2 June 2026 · 08:56 am AEST ⚡ Price SensitiveMaterial ASX Filing
Entropy completes Cohort 1 dosing in BED trial
Entropy Neurodynamics completes first cohort dosing in Phase 2 BED trial of TRP-8803
Progress Report
70
Entropy Neurodynamics Completes Dosing in First Cohort of IV Psilocin BED Trial Healthcare Wrap - Week 23 (1 June -> 5 June) 2026 Wrap

29 May 2026 · 11:07 am AEST ASX Filing
Application for quotation of securities - ENP
Appendix 2A
22 May 2026 · 01:32 pm AEST ASX Filing
Release of Securities from Escrow
Issued Capital - Other
15 May 2026 · 01:46 pm AEST ASX Filing
Notification of cessation of securities - ENP
Appendix 3H (Notification of cessation of securities)
14 May 2026 · 09:23 am AEST ASX Filing
Change of Director's Interest Notice - JC
Change of Director's Interest Notice
11 May 2026 · 09:44 am AEST ASX Filing
Australian Microcap Investment Conference presentation
Company Presentation
5 May 2026 · 09:38 am AEST ⚡ Price SensitiveMaterial ASX Filing
Entropy files new US patent for IBS program
Entropy Neurodynamics files new US patent to advance TRP-8803 IBS therapy following strong Phase 2a results
Web CastProgress Report
85
Entropy Neurodynamics Files New US Patent to Strengthen TRP-8803 IBS Therapy IP Healthcare Wrap - Week 19 (4 May -> 8 May) 2026 Wrap Market Wrap - Week 19 (4 May -> 8 May) 2026 Wrap
4 May 2026 · 09:08 am AEST ⚡ Price SensitiveMaterialUnexpected ASX Filing
TRP 8802 delivers 75% breakthrough response in IBS
Entropy Neurodynamics Reports 75% Response Rate in Phase 2a Trial of Oral Psilocybin Therapy for Treatment-Resistant IBS
Web CastProgress Report
90
Entropy Neurodynamics Reports 75% Response Rate in Phase 2a Trial of Oral Psilocybin Therapy for Treatment-Resistant IBS Healthcare Wrap - Week 19 (4 May -> 8 May) 2026 Wrap Market Wrap - Week 19 (4 May -> 8 May) 2026 Wrap

28 Apr 2026 · 09:29 am AEST ⚡ Price SensitiveMaterial ASX Filing
Quarterly Activities Report and Appendix 4C
Entropy Neurodynamics advances TRP-8803 clinical trial with positive early results and secures patent protection
Commitments Test Entity - Third Quarter Activity ReportCommitments Test Entity - Third Quarter Cashflow Report
85
Entropy Neurodynamics Reports Promising Early Results in TRP-8803 BED Trial and Secures Patent Protection Healthcare Wrap - Week 18 (27 Apr -> 1 May) 2026 Wrap
20 Apr 2026 · 02:53 pm AEST ASX Filing
Change of Director's Interest Notice - CN, DT, JC & HJ
Change of Director's Interest Notice
17 Apr 2026 · 04:45 pm AEST ASX Filing
Cleansing Notice
Cleansing Notice
17 Apr 2026 · 04:40 pm AEST ASX Filing
Application for quotation of securities - ENP
Appendix 2A
14 Apr 2026 · 10:49 am AEST ASX Filing
Cleansing Notice
Cleansing Notice
14 Apr 2026 · 10:47 am AEST ASX Filing
Application for quotation of securities - ENP
Appendix 2A
14 Apr 2026 · 09:29 am AEST ⚡ Price SensitiveMaterial ASX Filing
TRP-8803 delivers repeatable, high-intensity effect
Entropy Neurodynamics doses third patient in TRP-8803 BED trial achieving controlled psychedelic response
Progress Report
85
Entropy Neurodynamics Advances Controlled Psychedelic Therapy in Binge Eating Disorder Trial Healthcare Wrap - Week 16 (13 Apr -> 17 Apr) 2026 Wrap